艾美疫苗(06660)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06660 艾美疫苗

未开盘 11-18 16:08:08

6.830

-0.160

-2.29%

最高7.350	最低6.820	成交量293.14万
今开7.110	昨收6.990	日振幅7.58%
总市值82.72亿	流通市值33.60亿	总股本12.11亿
成交额2,069万	换手率0.60%	流通股本4.92亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06660","market":"HK","secType":"STK","nameCN":"艾美疫苗","latestPrice":6.83,"timestamp":1731917288023,"preClose":6.99,"halted":0,"volume":2931400,"delay":0,"floatShares":492000000,"shares":1211062599,"eps":-1.1570541,"marketStatus":"未开盘","marketStatusCode":0,"change":-0.16,"latestTime":"11-18 16:08:08","open":7.11,"high":7.35,"low":6.82,"amount":20690786,"amplitude":0.075823,"askPrice":6.88,"askSize":6000,"bidPrice":6.83,"bidSize":7400,"shortable":3,"etf":0,"ttmEps":-1.0582334854240454,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1731979800000},"adr":0,"listingDate":1664985600000,"adjPreClose":6.99,"openAndCloseTimeList":[[1731893400000,1731902400000],[1731906000000,1731916800000]],"volumeRatio":0.4313216564239265,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06660/tweets","defaultTab":"tweets","newsList":[{"id":"2484988116","title":"不到一个月，两大重磅疫苗接连冲刺上市，艾美疫苗进入商业化收获期","url":"https://stock-news.laohu8.com/highlight/detail?id=2484988116","media":"时代财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484988116?lang=zh_cn&edition=full","pubTime":"2024-11-18 10:27","pubTimestamp":1731896838,"startTime":"0","endTime":"0","summary":"本文来源：时代财经 作者：张路艾美疫苗（06660.HK）在研产品捷报频传。11月17日，艾美疫苗发布公告称，本集团自主研发的无血清迭代狂犬病疫苗已向国家药品监督管理局（下称“国家药监局）”提交上市注册预申请。就在半个多月前，艾美疫苗刚宣布，其自主研发的13价结合肺炎疫苗已向国家药监局提交药品上市注册。11月15日，...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/ONYNmpB9CpNb7VunhTWN-2-wogOVrE4ChUwcNBfttMfxAAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/ONYNmpB9CpNb7VunhTWN-2-wogOVrE4ChUwcNBfttMfxAAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20241118A02S8700","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20241118A02S8700","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent_tech","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2484665049","title":"引领大单品迭代创新 艾美疫苗无血清迭代狂犬病疫苗已提交上市注册预申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2484665049","media":"中国网财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484665049?lang=zh_cn&edition=full","pubTime":"2024-11-18 08:46","pubTimestamp":1731890793,"startTime":"0","endTime":"0","summary":"正在加速推进狂犬疫苗迭代升级的艾美疫苗，在新品研发上再获新战果。艾美疫苗11月17日发布公告称，公司自主研发的无血清迭代狂犬病疫苗已于近日向国家药品监督管理局提交上市注册预申请。艾美疫苗表示，根据已完成揭盲的Ⅲ期临床研究结果显示，公司的无血清迭代狂犬病疫苗具有良好的安全性、免疫原性和免疫持久性，达到临床预设目标。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202411183241880920.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411183241880920.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2484650976","title":"【湾区早参】香港与内地资本市场互联互通机制迎来十周年；香港与秘鲁签订自由贸易协定","url":"https://stock-news.laohu8.com/highlight/detail?id=2484650976","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484650976?lang=zh_cn&edition=full","pubTime":"2024-11-18 08:31","pubTimestamp":1731889902,"startTime":"0","endTime":"0","summary":"在港股通方面，截至2024年9月底，南向资金累计净流入近3.4万亿港元。期内集团收入10.55亿元，同比增长36.01%。期内，货邮周转量同比上升21.08%。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/YjE5MTg4YjVmOWZlYmUxNDMyNzYzODgyMzAy.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YjE5MTg4YjVmOWZlYmUxNDMyNzYzODgyMzAy.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1947854","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1538","01336","00753","159982","BK1550","BK1161","BK1137","BK1514","BK1561","01898","BK1184","BK1191","BK1590","BK1123","01860","BK1586","BK1594","00670","01088","BK1584","LU0173614495.USD","BK1574","LU0287142896.SGD","BK1178","BK1515","BK1505","BK1555","BK1518","06185","399300","06660","01055","02777","BK1240"],"gpt_icon":0},{"id":"2484768783","title":"港股公告掘金 | 阿里巴巴-W第二季度净利润435.47亿元 同比增加63% 高德日活跃用户峰值超过3亿创历史新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2484768783","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484768783?lang=zh_cn&edition=full","pubTime":"2024-11-17 20:11","pubTimestamp":1731845492,"startTime":"0","endTime":"0","summary":"重大事项：君实生物(01877)： 特瑞普利单抗获得英国药品和保健品管理局批准上市艾美疫苗(06660)：无血清迭代狂犬疫苗已提交上市注册预申请柏能集团(01263)成功以介绍形式于新加坡证券交易所进行第二上市普达特科技(00650)上半年半导体设备业务稳步推进，取得显著进展中国同辐(01763)：华北高科成功取得生态环保部颁发的辐射安全许可证中国同辐(01763)：武汉高科锝标记药物二期新生产线","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1211977.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01088","HSCEI","BABA","HSTECH","YANG","06660","00650","00992","09988"],"gpt_icon":1},{"id":"2484959684","title":"艾美疫苗提交无血清狂犬疫苗上市申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2484959684","media":"财中社","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484959684?lang=zh_cn&edition=full","pubTime":"2024-11-17 19:09","pubTimestamp":1731841797,"startTime":"0","endTime":"0","summary":"财中社11月17日电艾美疫苗（06660）发布公告，通知股东及潜在投资者其最新业务进展。公司已向国家药品监督管理局提交无血清迭代狂犬疫苗的上市注册预申请。根据已完成的III期临床研究结果，该疫苗显示出良好的安全性、免疫原性和免疫持久性，达到了临床预设目标。目前，全球市场尚未有无血清狂犬疫苗获批上市，公司的产品有望成为首个上市的无血清狂犬疫苗。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411173241790884.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","06660"],"gpt_icon":0},{"id":"2484178686","title":"艾美疫苗(06660)：无血清迭代狂犬疫苗已提交上市注册预申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2484178686","media":"智通财经","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484178686?lang=zh_cn&edition=full","pubTime":"2024-11-17 18:17","pubTimestamp":1731838651,"startTime":"0","endTime":"0","summary":"智通财经APP讯，艾美疫苗 发布公告，集团自主研发的无血清迭代狂犬疫苗已于近日向国家药品监督管理局提交上市注册预申请。疫苗产品中的动物血清残留是导致疫苗接种人群产生过敏等不良反应的重要因素之一，集团研发的无血清迭代狂犬疫苗，不含有动物血清，显著提高了安全性，降低了不良反应的概率。截至目前，全球市场上尚未有无血清狂犬疫苗获批上市，该产品有望成为首个上市产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1211964.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06660","BK1161","159646"],"gpt_icon":0},{"id":"2483613433","title":"南向资金11月13日净买入艾美疫苗32.88万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2483613433","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483613433?lang=zh_cn&edition=full","pubTime":"2024-11-15 09:30","pubTimestamp":1731634210,"startTime":"0","endTime":"0","summary":"11月13日, 南向资金增持艾美疫苗32.88万股，连续5日增持。截止当日收盘，港股通共持有艾美疫苗5796.16万股，占流通股11.77%。艾美疫苗近5个交易日下跌2.11%，港股通累计增持172.10万股；近20个交易日上涨35.22%，港股通累计增持1502.78万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115093023abc2a6a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115093023abc2a6a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2483181170","title":"艾美疫苗(06660)股价下跌8.259%，现价港币$7.22","url":"https://stock-news.laohu8.com/highlight/detail?id=2483181170","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483181170?lang=zh_cn&edition=full","pubTime":"2024-11-14 14:05","pubTimestamp":1731564300,"startTime":"0","endTime":"0","summary":"[下跌股]艾美疫苗(06660) 股价在下午02:05比前收市价下跌8.259%，现股价为港币$7.22。至目前为止，今日最高价为$7.96，而最低价为$7.22。总成交量为357.84万股，总成交金额为港币$2.719千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152745608_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152745608_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2411142085/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","06660"],"gpt_icon":0},{"id":"2483815005","title":"艾美疫苗(06660)下跌5.21%，报7.46元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483815005","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483815005?lang=zh_cn&edition=full","pubTime":"2024-11-14 13:34","pubTimestamp":1731562468,"startTime":"0","endTime":"0","summary":"11月14日，艾美疫苗(06660)盘中下跌5.21%，截至13:34，报7.46元/股，成交1896.0万元。艾美疫苗股份有限公司是中国第二大疫苗供应商，涵盖了从研发到制造、再到商业化的整个价值链，并在全球范围内拥有五种经过验证的人用疫苗平台技术。2021年销售收入市场份额为2.1%，批签发量在所有民营疫苗公司中处于领先地位，同时也是中国首批获得P3实验室建设许可的疫苗企业之一。截至2024年中报，艾美疫苗营业总收入5.37亿元、净利润-1.39亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/14133445281985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2483815446","title":"艾美疫苗盘中异动 股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483815446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483815446?lang=zh_cn&edition=full","pubTime":"2024-11-14 13:34","pubTimestamp":1731562467,"startTime":"0","endTime":"0","summary":"2024年11月14日下午盘13时34分，艾美疫苗股票出现异动，股价快速下跌5.21%。截至发稿，该股报7.460港元/股，成交量246.9万股，换手率0.50%，振幅6.35%。资金方面，该股资金流入450.126万港元，流出999.406万港元。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。艾美疫苗股票所在的药品行业中，整体跌幅为0.01%。艾美疫苗公司简介：艾美疫苗股份有限公司是一家主要从事疫苗研发、制造和销售的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114133427a236263a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114133427a236263a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2482712108","title":"艾美疫苗盘中涨超7% 迭代二倍体狂犬疫苗申报临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2482712108","media":"新浪港股","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482712108?lang=zh_cn&edition=full","pubTime":"2024-11-12 11:58","pubTimestamp":1731383888,"startTime":"0","endTime":"0","summary":"艾美疫苗（06660）盘中涨超7%，截至发稿，股价上涨5.26%，现报8.20港元，成交额6436.89万港元。\n　　艾美疫苗公告，集团研发的迭代工艺高效价人二倍体狂犬疫苗已于近日向中国药品监督管理局药品审评中心（CDE）申报临床。据悉，集团已建设完成满足国际化标准的迭代工艺高效价人二倍体狂犬病疫苗车间，并已完成商业化规模的三期临床试验样品的生产，具备该产品规模化生产的能力。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-11-12/doc-incvupac1640242.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-11-12/doc-incvupac1640242.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2482194977","title":"港股异动 | 艾美疫苗(06660)盘中涨超7% 迭代二倍体狂犬疫苗申报临床 近期公布多款产品申报进展","url":"https://stock-news.laohu8.com/highlight/detail?id=2482194977","media":"智通财经","labels":["Product Release","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482194977?lang=zh_cn&edition=full","pubTime":"2024-11-12 11:13","pubTimestamp":1731381222,"startTime":"0","endTime":"0","summary":"消息面上，艾美疫苗公告，集团研发的迭代工艺高效价人二倍体狂犬疫苗已于近日向中国药品监督管理局药品审评中心申报临床。据悉，集团已建设完成满足国际化标准的迭代工艺高效价人二倍体狂犬病疫苗车间，并已完成商业化规模的三期临床试验样品的生产，具备该产品规模化生产的能力。此外，艾美疫苗本月初发布公告称，公司自主研发的13价结合肺炎疫苗已向国家药品监督管理局提交药品上市注册。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1209658.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06660","BK1161","159646"],"gpt_icon":0},{"id":"2482715798","title":"艾美疫苗盘中异动 急速拉升5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482715798","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482715798?lang=zh_cn&edition=full","pubTime":"2024-11-12 10:38","pubTimestamp":1731379116,"startTime":"0","endTime":"0","summary":"2024年11月12日早盘10时38分，艾美疫苗股票出现波动，股价大幅上涨5.01%。截至发稿，该股报8.180港元/股，成交量487.92万股，换手率0.99%，振幅7.19%。艾美疫苗股票所在的药品行业中，整体涨幅为0.54%。其相关个股中，艾美疫苗、培力农本方、凯莱英涨幅较大，振幅较大的相关个股有君圣泰医药-B、培力农本方、凯莱英，振幅分别为15.65%、9.09%、8.46%。艾美疫苗公司简介：艾美疫苗股份有限公司是一家主要从事疫苗研发、制造和销售的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112103836a22e4489&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112103836a22e4489&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2482716844","title":"艾美疫苗(06660)上涨5.01%，报8.18元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2482716844","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482716844?lang=zh_cn&edition=full","pubTime":"2024-11-12 10:38","pubTimestamp":1731379115,"startTime":"0","endTime":"0","summary":"11月12日，艾美疫苗(06660)盘中上涨5.01%，截至10:38，报8.18元/股，成交3881.02万元。艾美疫苗股份有限公司是中国第二大疫苗供应商，涵盖了从研发到制造、再到商业化的整个价值链，并在全球范围内拥有五种经过验证的人用疫苗平台技术。2021年销售收入市场份额为2.1%，批签发量在所有民营疫苗公司中处于领先地位，同时也是中国首批获得P3实验室建设许可的疫苗企业之一。截至2024年中报，艾美疫苗营业总收入5.37亿元、净利润-1.39亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/11/12103845180533.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","06660"],"gpt_icon":0},{"id":"2482718573","title":"南向资金11月11日净买入艾美疫苗15.06万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2482718573","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482718573?lang=zh_cn&edition=full","pubTime":"2024-11-12 09:30","pubTimestamp":1731375019,"startTime":"0","endTime":"0","summary":"11月11日, 南向资金增持艾美疫苗15.06万股，连续3日增持。截止当日收盘，港股通共持有艾美疫苗5713.36万股，占流通股11.60%。艾美疫苗近5个交易日下跌7.26%，港股通累计增持179.72万股；近20个交易日上涨24.44%，港股通累计增持1722.68万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112093311abb78bec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112093311abb78bec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2482027127","title":"艾美疫苗11月11日主力资金流出403万元 连续7日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2482027127","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482027127?lang=zh_cn&edition=full","pubTime":"2024-11-11 16:17","pubTimestamp":1731313020,"startTime":"0","endTime":"0","summary":"11月11日, 艾美疫苗股价跌2.26%，报收7.79元，成交金额4179万元，换手率1.10%，振幅3.76%，量比0.61。艾美疫苗今日主力资金净流出403万元，连续7日净流出，上一交易日主力净流出366万元，今日环比增加10.11%。该股近5个交易日下跌7.14%，主力资金累计净流出1722万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出666万元，其中净流出天数为13日。该股主力净额占比0.10%，港股市场排名2601/2643。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111161754a22be158&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111161754a22be158&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06660","BK1161"],"gpt_icon":0},{"id":"2482212546","title":"金十数据整理：每日港股市场要闻速递（11月11日 周一）","url":"https://stock-news.laohu8.com/highlight/detail?id=2482212546","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482212546?lang=zh_cn&edition=full","pubTime":"2024-11-11 09:16","pubTimestamp":1731287778,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["01672","BK1589","02288","LU0348735423.USD","02150","BK0201","HSTECH","HSHD.SI","BK1574","BK1507","BK1547","00005","LU1481107354.HKD","IE0034224299.USD","BK1233","BK0175","BK1170","601238","02382","LU0326950275.SGD","BK1607","03143","02238","01811","YANG","BK1526","00754","BK1191","BK1231","00981","BK1608","00341","01347","06660","HSBC","HSBA.UK","BK4588","LU0417516738.SGD","BK1240","01477","02202","LU0634319403.HKD","07226","000002","159646","BK1521","HSCEI","00960","LU1064131003.USD","688981"],"gpt_icon":0},{"id":"2481162030","title":"【港股通】艾美疫苗(06660)涨超4% 迭代工艺高效价人二倍体狂犬疫苗申报临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2481162030","media":"金吾财讯","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481162030?lang=zh_cn&edition=full","pubTime":"2024-11-08 10:22","pubTimestamp":1731032546,"startTime":"0","endTime":"0","summary":"金吾财讯 | 艾美疫苗(06660)早盘股价强势，截至发稿，报8.18港元，涨4.47%，成交额4349.4万港元。消息面上，公司公布，迭代工艺高效价人二倍体狂犬疫苗已于近日向国家药品监督管理局药品审评中心申报临床。目前市场上的人二倍体狂犬疫苗价格比Vero细胞狂犬疫苗高3至5倍。该集团指已具备该产品规模化生产能力。","market":"hk","thumbnail":"https://static.szfiu.com/news/20210810/ZDVjZjI4MzkxNjI4NTkwMDQ5NTQ5.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZDVjZjI4MzkxNjI4NTkwMDQ5NTQ5.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1947349","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSTECH","06660","159646","BK1161","YANG","HSCEI"],"gpt_icon":0},{"id":"2481629771","title":"艾美疫苗盘中拉升逾8% 迭代工艺高效价人二倍体狂犬疫苗申报临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2481629771","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481629771?lang=zh_cn&edition=full","pubTime":"2024-11-08 09:52","pubTimestamp":1731030720,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　艾美疫苗（06660）早盘一度拉升逾8%，截至发稿，股价上涨5.49%，现报8.26港元，成交额3166.37万港元。\n　　消息面上，艾美疫苗发布公告，该集团研发的迭代工艺高效价人二倍体狂犬疫苗已于近日向中国药品监督管理局药品审评中心（CDE）申报临床。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-11-08/doc-incvihkr2205930.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-11-08/doc-incvihkr2205930.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","159646","06660"],"gpt_icon":0},{"id":"2481169864","title":"金十数据整理：每日港股市场要闻速递（11月8日 周五）","url":"https://stock-news.laohu8.com/highlight/detail?id=2481169864","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481169864?lang=zh_cn&edition=full","pubTime":"2024-11-08 09:10","pubTimestamp":1731028223,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["01477","BK0264","BK1191","00341","BK4588","LU2236285917.USD","HSTECH","HSHD.SI","02238","LU0320764599.SGD","LU0634319403.HKD","BK1587","IE0034224299.USD","688981","HSBC","LU1064131003.USD","SG9999006597.SGD","01672","159646","BK4521","HSBA.UK","BK0183","BK4585","BK0196","LU0417516738.SGD","00981","BK0175","01347","02288","02150","00005","BK0188","BK1231","BK1526","07226","BK1589","HSCEI","LU0540923850.HKD","LU0052750758.USD","LU0164880469.USD","YANG","03143","BK1577","06660","BK1610","LU1064130708.USD","BK0187","BK1161","LU2148510915.USD","601238"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aimbio.com","stockEarnings":[{"period":"1week","weight":-0.1232},{"period":"1month","weight":-0.0243},{"period":"3month","weight":0.2131},{"period":"6month","weight":-0.1013},{"period":"1year","weight":-0.2478},{"period":"ytd","weight":-0.1299}],"compareEarnings":[{"period":"1week","weight":-0.0416},{"period":"1month","weight":-0.059},{"period":"3month","weight":0.118},{"period":"6month","weight":0.0198},{"period":"1year","weight":0.1216},{"period":"ytd","weight":0.1484}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"艾美疫苗股份有限公司是一家主要从事疫苗研发、制造和销售的中国公司。该公司的产品主要包括重组乙型肝炎疫苗、人用狂犬病疫苗、甲型肝炎灭活疫苗、腮腺炎疫苗、肾综合征出血热灭活疫苗和MPSV4。该公司的产品主要用于治疗乙肝、甲肝、腮腺炎、肾综合征出血热、狂犬病和脑膜炎球菌病。该公司的在研疫苗包括信使核糖核酸（mRNA）新冠（COVID-19）疫苗、灭活新冠疫苗、广谱新冠疫苗、PCV13、PPSV23及MCV4。该公司主要在国内市场开展业务。","exchange":"SEHK","name":"艾美疫苗","nameEN":"AIM VACCINE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾美疫苗(06660)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾美疫苗(06660)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾美疫苗,06660,艾美疫苗股票,艾美疫苗股票老虎,艾美疫苗股票老虎国际,艾美疫苗行情,艾美疫苗股票行情,艾美疫苗股价,艾美疫苗股市,艾美疫苗股票价格,艾美疫苗股票交易,艾美疫苗股票购买,艾美疫苗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾美疫苗(06660)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾美疫苗(06660)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}